2-[C-11]thymidine imaging of malignant brain tumors

Cancer Research

Volumn 59, Issue 3, 1999, Pages 615-621

  Eary, Janet F ^a   Mankoff, David A ^a   Spence, Alexander M ^a   Berger, Mitchel S ^a   Olshen, Adam ^a   Link, Jeanne M ^a   O'Sullivan, Finbarr ^a   Krohn, Kenneth A ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; THYMIDINE C 11; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NEUROECTODERM TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

ASTROCYTOMA; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CARBON DIOXIDE; CARBON RADIOISOTOPES; GLIOBLASTOMA; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033083180     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Di Chiro, G. and Brooks, R. PET-FDG of untreated and treated cerebral gliomas. J. Nucl. Med., 29: 421-422, 1988.
2. Di Chiro, G., Oldfield, E., Wright, D. C., De Michele, D., Katz, D. A., Patronas, N. J., Doppman, J. L., Larson, S. M., Ito, M., and Kufta, C. V. Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies. Am. J. Roentgenol., 150: 180-197, 1988.
3. Kapoor, R., Spence, A. M., Muzi, M., Graham, M. M., Abbott, G. L., and Krohn, K. A. Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma. J. Neurochem., 53: 37-44, 1989.
4. Spence, A. M., Muzi, M., Graham, M. M., Freeman, S. D., Berger, M. S., and Ojemann, G. A. Analysis of the deoxyglucose lumped constant in human malignant gliomas. Ann. Neurol., 30: 271-272, 1991.
5. Livingston, R., and Hart, J. The clinical applications of cell kinetics in cancer therapy. Ann. Rev. Pharmacol. Toxicol., 17: 529-543, 1977.
6. Larson, S. M., Weiden, P. L., Grunbaum, Z., Rasey, J. S., Kaplan, H. G., Graham, M. M., Harp, G. D., Sale, G. E., and Williams, D. L. Positron imaging feasibility studies I: characteristics of [H-3]thymidine uptake in rodent and canine neoplasms: concise communication. J. Nucl. Med., 22: 869-874, 1981.
7. Mankoff, D., Shields, A., Graham, M., Link, J., Eary, J., and Krohn, K. A graphical analysis method to estimate blood-to-tissue transfer constants for systems with labeled metabolites. J. Nucl. Med., 37: 2049-2057, 1996.
8. Mankoff, D. A., Shields, A. F., Graham, M. M., Link, J. M., Eary, J. F., and Krohn, K. A. Kinetic analysis of 2-[C-11]thymidine PET imaging studies: compartmental model and mathematical analysis. J. Nucl. Med., 39: 1403-1455, 1998.
9. Shields, A., Larson, S., Grunbaum, Z., and Graham, M., Short-term uptake in normal and neoplastic tissues: studies for PET. J. Nucl. Med., 25: 759-764, 1984.
10. Shields, A., Lim, K., Grierson, J., Link, J., and Krohn, K. Utilization of labeled lhymidine in DNA synthesis: studies for PET. J. Nucl. Med., 31: 337-342, 1990.
11. Shields, A. F., Graham, M. M., Kozava, S. M., Kozell, L. B., Link, J. M., Swenson, E. R., Spence, A.M., Bassingthwaighte, J. B., and Krohn, K. A. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J. Nucl. Med., 33: 581-584, 1992.
12. Shields, A., Mankoft, D., Graham, M., Zheng, M., Kozawa, S. M., Link, J. M., and Krohn, K. A. Analysis of 2-[carbon-[1]thymidine blood metabolites in PET imaging. J. Nucl. Med., 37: 290-296, 1996.
13. 11C]thymidine and FDG with positron emission tomography (PET) to measure response to therapy J. Nucl. Med., in press.
14. Lonneux, M., Labar, D., Bol, A., Jamar, F., and Pauwels, S. Uptake of 2-11-C thymidine in colonic and bronchial tumors. In: Metabolic Imaging of Cancer: Proceedings of the European Conference on Research and Application of Positron Emission Tomography in Oncology. Groningen, the Netherlands: PET-Centrum AZG, 1996.
15. Alavi, J. B., Alavi, A., Chawluk, J., Kushner, M., Powe, J., Hickey, W., and Reivich, M. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer (Phila.), 62: 1074-1078, 1988.
16. Link, J. M., Grierson, J., and Krohn, K. Alternatives in the synthesis of 2-[C-11]thymidine. J. Labelled Compd Radiopharm., 37: 610-612, 1995.
17. 11C]thymidine for quantification of cellular proliferation with PET. Appl. Radiat. Isotopes, 42: 103-104, 1991.
18. 2 and Positron Emission Tomography. J. Cereb. Blood Flow Metab., 4: 458-465, 1984.
19. 2 and positron emission tomography. J. Cereb. Blood Flow Metab., 4: 8-16, 1984.
20. Comford, E., and Oldendorf, W. Independent blood-brain harrier transport systems for nucleic acid precursors. Biochim. Biophys. Acta. 394: 211-219, 1975.
21. Hamacher, K., Coenen, H., and Stocklin, G. Efficient sterospecific synthesis of no-carrier-added 2-[18F]fluovo-2-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med., 27: 235-238, 1986.
22. Vander Borght, T., Pauwels, S., Lambotte, L., and Beckers, C. Rapid synthesis of 2C-radiolabelled thymidine (2C-dThd), a potential tracer for measurement of liver regeneration. J. Nucl. Med., 10: 929P, 1989.
23. Lewellen, T. K., Kohlmeyer, S., Miyaoka, R., Schubert, S., and Steams, C. Investigation of the count rate performance of the General Electric ADVANCE positron emission tomograph. IEEE (Inst. Electr. Electron. Eng.) Trans. Nucl. Sci., 42: 1051-1057, 1995.
24. O'Sullivan, F. Metabolic images from dynamic positron emission tomography studies. Stat. Methods Med. Res., 3: 87-101, 1994.
25. O'Sullivan, F., Muzi, M., and Graham, M. Parametric imaging by mixture analysis in 3D: validation for dual tracer glucose studies. Neuro. Imag., 2: 556, 1995.